Will GoodRX Stock Bounce Back?
GoodRX (NASDAQ:GDRX) tracks prescription drug prices and its model was…
Buy
56
ZVRA Quote, Financials, Valuation and Earnings
Last price:
$12.66
Seasonality move
:
11.56%
Day range:
$12.17 - $12.89
52-week range:
$5.45 - $13.16
Dividend yield:
0%
P/E ratio:
--
P/S ratio:
14.97x
P/B ratio:
16.42x
Volume:
1.6M
Avg. volume:
1M
1-year change:
88.38%
Market cap:
$673.7M
Revenue:
$23.6M
EPS (TTM):
-$1.92
| Period Ending | 2020-12-31 | 2021-12-31 | 2022-12-31 | 2023-12-31 | 2024-12-31 | |
|---|---|---|---|---|---|---|
| Revenue | $13.3M | $28.7M | $10.2M | $27.5M | $23.6M | |
| Revenue Growth (YoY) | 3.5% | 115.61% | -64.53% | 170.26% | -14.02% | |
| Cost of Revenues | $1.3M | $2.1M | $222K | $2.2M | $7.4M | |
| Gross Profit | $12M | $26.6M | $9.9M | $25.3M | $16.2M | |
| Gross Profit Margin | 90.18% | 92.81% | 97.82% | 92.09% | 68.59% | |
| R&D Expenses | $8.8M | $10.2M | $19.8M | $39.8M | $42.1M | |
| Selling, General & Admin | $7.9M | $8.7M | $15M | $34.3M | $54.9M | |
| Other Inc / (Exp) | -$1M | -$16.1M | -$3.1M | $515K | $2M | |
| Operating Expenses | $16.8M | $18.9M | $34.8M | $74.9M | $103.2M | |
| Operating Income | -$4.8M | $7.7M | -$24.9M | -$49.6M | -$87M | |
| Net Interest Expenses | $7M | $115K | -- | -- | $5.2M | |
| EBT. Incl. Unusual Items | -$12.8M | -$8.5M | -$26.8M | -$46M | -$90.1M | |
| Earnings of Discontinued Ops. | -- | -- | -- | -- | -- | |
| Income Tax Expense | -$34K | $34K | -$33K | -- | $15.4M | |
| Net Income to Company | -$12.8M | -$8.6M | -$26.8M | -$46M | -$105.5M | |
| Minority Interest in Earnings | -- | -- | -- | -- | -- | |
| Net Income to Common Excl Extra Items | -$12.8M | -$8.6M | -$26.8M | -$46M | -$105.5M | |
| Basic EPS (Cont. Ops) | -$3.21 | -$2.11 | -$0.78 | -$1.30 | -$2.28 | |
| Diluted EPS (Cont. Ops) | -$3.21 | -$2.11 | -$0.78 | -$1.30 | -$2.28 | |
| Weighted Average Basic Share | $4M | $29.8M | $34.5M | $35.5M | $46.3M | |
| Weighted Average Diluted Share | $4M | $29.8M | $34.5M | $35.5M | $46.3M | |
| EBITDA | -$5.4M | -$7.9M | -$25.5M | -$43.5M | -$76.4M | |
| EBIT | -$5.7M | -$8.1M | -$26.5M | -$44.5M | -$82.8M | |
| Revenue (Reported) | $13.3M | $28.7M | $10.2M | $27.5M | $23.6M | |
| Operating Income (Reported) | -$4.8M | $7.7M | -$24.9M | -$49.6M | -$87M | |
| Operating Income (Adjusted) | -$5.7M | -$8.1M | -$26.5M | -$44.5M | -$82.8M | |
| Period Ending | 2021-03-31 | 2022-03-31 | 2023-03-31 | 2024-03-31 | 2025-03-31 | |
|---|---|---|---|---|---|---|
| Revenue | $12.1M | $4M | $3.2M | $3.4M | $20.4M | |
| Revenue Growth (YoY) | 480.04% | -67.28% | -19.9% | 7.84% | 495.65% | |
| Cost of Revenues | $1M | $8K | $125K | $175K | $1.3M | |
| Gross Profit | $11.1M | $4M | $3.1M | $3.3M | $19.1M | |
| Gross Profit Margin | 91.75% | 99.8% | 96.06% | 94.89% | 93.41% | |
| R&D Expenses | $2.3M | $3.1M | $8.7M | $12.3M | $3.3M | |
| Selling, General & Admin | $1.9M | $2.7M | $7.2M | $9.9M | $19.5M | |
| Other Inc / (Exp) | -$16.9M | -$111K | -$1.3M | $3.6M | $4.9M | |
| Operating Expenses | $4.2M | $5.8M | $15.9M | $23.7M | $24.4M | |
| Operating Income | $7M | -$1.9M | -$12.8M | -$20.5M | -$5.4M | |
| Net Interest Expenses | $341K | -- | -- | -- | $1.4M | |
| EBT. Incl. Unusual Items | -$10.3M | -$1.9M | -$13.3M | -$16.7M | -$1.9M | |
| Earnings of Discontinued Ops. | -- | -- | -- | -- | -- | |
| Income Tax Expense | -- | -$4K | -$103K | -$70K | $1.2M | |
| Net Income to Company | -$10.3M | -$1.9M | -$13.2M | -$16.6M | -$3.1M | |
| Minority Interest in Earnings | -- | -- | -- | -- | -- | |
| Net Income to Common Excl Extra Items | -$10.3M | -$1.9M | -$13.2M | -$16.6M | -$3.1M | |
| Basic EPS (Cont. Ops) | -$2.49 | -$0.05 | -$0.38 | -$0.40 | -$0.06 | |
| Diluted EPS (Cont. Ops) | -$2.49 | -$0.05 | -$0.38 | -$0.40 | -$0.06 | |
| Weighted Average Basic Share | $19.1M | $34.5M | $34.5M | $41.8M | $54.1M | |
| Weighted Average Diluted Share | $19.1M | $34.5M | $34.5M | $41.8M | $54.1M | |
| EBITDA | -$9.9M | -$1.8M | -$13.1M | -$14.4M | $1.7M | |
| EBIT | -$9.9M | -$1.9M | -$13.1M | -$16M | $52K | |
| Revenue (Reported) | $12.1M | $4M | $3.2M | $3.4M | $20.4M | |
| Operating Income (Reported) | $7M | -$1.9M | -$12.8M | -$20.5M | -$5.4M | |
| Operating Income (Adjusted) | -$9.9M | -$1.9M | -$13.1M | -$16M | $52K | |
| Period Ending | 2021-03-31 | 2022-03-31 | 2023-03-31 | 2024-03-31 | 2025-03-31 | |
|---|---|---|---|---|---|---|
| Revenue | $23.3M | $20.5M | $9.4M | $27.7M | $40.6M | |
| Revenue Growth (YoY) | -- | -- | -- | -- | -- | |
| Cost of Revenues | -- | -- | $339K | $2.2M | $8.6M | |
| Gross Profit | $21.7M | $19.4M | $9M | $25.5M | $32M | |
| Gross Profit Margin | -- | -- | -- | -- | -- | |
| R&D Expenses | $9M | $11M | $43M | $43.4M | $33.1M | |
| Selling, General & Admin | $7.6M | $9.5M | $19.5M | $37M | $64.5M | |
| Other Inc / (Exp) | -$17.2M | $669K | $13.1M | $5.5M | $3.3M | |
| Operating Expenses | $16.6M | $20.5M | $62.6M | $82.7M | $103.9M | |
| Operating Income | $5.1M | -$1.1M | -$53.5M | -$57.3M | -$71.9M | |
| Net Interest Expenses | $5.3M | -- | -- | -- | $6.8M | |
| EBT. Incl. Unusual Items | -$17.3M | -$93K | -$38.3M | -$49.4M | -$75.4M | |
| Earnings of Discontinued Ops. | -- | -- | -- | -- | -- | |
| Income Tax Expense | -$34K | $30K | -$132K | $33K | $16.6M | |
| Net Income to Company | -$17.3M | -$123K | -$38.1M | -$49.5M | -$92M | |
| Minority Interest in Earnings | -- | -- | -- | -- | -- | |
| Net Income to Common Excl Extra Items | -$17.3M | -$123K | -$38.1M | -$49.5M | -$92M | |
| Basic EPS (Cont. Ops) | -$4.09 | -$0.45 | -$1.11 | -$1.32 | -$1.92 | |
| Diluted EPS (Cont. Ops) | -$4.09 | -$0.45 | -$1.11 | -$1.32 | -$1.92 | |
| Weighted Average Basic Share | ||||||
| Weighted Average Diluted Share | ||||||
| EBITDA | -$11.6M | $206K | -$36.8M | -$44.9M | -$60.3M | |
| EBIT | -$11.9M | -$52K | -$37.7M | -$47.4M | -$66.8M | |
| Revenue (Reported) | $23.3M | $20.5M | $9.4M | $27.7M | $40.6M | |
| Operating Income (Reported) | $5.1M | -$1.1M | -$53.5M | -$57.3M | -$71.9M | |
| Operating Income (Adjusted) | -$11.9M | -$52K | -$37.7M | -$47.4M | -$66.8M | |
| Period Ending | 2021-03-31 | 2022-03-31 | 2023-03-31 | 2024-03-31 | 2025-03-31 | |
|---|---|---|---|---|---|---|
| Revenue | $12.1M | $4M | $3.2M | $3.4M | $20.4M | |
| Revenue Growth (YoY) | -- | -- | -- | -- | -- | |
| Cost of Revenues | $1M | $8K | $125K | $175K | $1.3M | |
| Gross Profit | $11.1M | $4M | $3.1M | $3.3M | $19.1M | |
| Gross Profit Margin | -- | -- | -- | -- | -- | |
| R&D Expenses | $2.3M | $3.1M | $8.7M | $12.3M | $3.3M | |
| Selling, General & Admin | $1.9M | $2.7M | $7.2M | $9.9M | $19.5M | |
| Other Inc / (Exp) | -$16.9M | -$111K | -$1.3M | $3.6M | $4.9M | |
| Operating Expenses | $4.2M | $5.8M | $15.9M | $23.7M | $24.4M | |
| Operating Income | $7M | -$1.9M | -$12.8M | -$20.5M | -$5.4M | |
| Net Interest Expenses | $341K | -- | -- | -- | $1.4M | |
| EBT. Incl. Unusual Items | -$10.3M | -$1.9M | -$13.3M | -$16.7M | -$1.9M | |
| Earnings of Discontinued Ops. | -- | -- | -- | -- | -- | |
| Income Tax Expense | -- | -$4K | -$103K | -$70K | $1.2M | |
| Net Income to Company | -$10.3M | -$1.9M | -$13.2M | -$16.6M | -$3.1M | |
| Minority Interest in Earnings | -- | -- | -- | -- | -- | |
| Net Income to Common Excl Extra Items | -$10.3M | -$1.9M | -$13.2M | -$16.6M | -$3.1M | |
| Basic EPS (Cont. Ops) | -$2.49 | -$0.05 | -$0.38 | -$0.40 | -$0.06 | |
| Diluted EPS (Cont. Ops) | -$2.49 | -$0.05 | -$0.38 | -$0.40 | -$0.06 | |
| Weighted Average Basic Share | $19.1M | $34.5M | $34.5M | $41.8M | $54.1M | |
| Weighted Average Diluted Share | $19.1M | $34.5M | $34.5M | $41.8M | $54.1M | |
| EBITDA | -$9.9M | -$1.8M | -$13.1M | -$14.4M | $1.7M | |
| EBIT | -$9.9M | -$1.9M | -$13.1M | -$16M | $52K | |
| Revenue (Reported) | $12.1M | $4M | $3.2M | $3.4M | $20.4M | |
| Operating Income (Reported) | $7M | -$1.9M | -$12.8M | -$20.5M | -$5.4M | |
| Operating Income (Adjusted) | -$9.9M | -$1.9M | -$13.1M | -$16M | $52K | |
| Period Ending | 2020-12-31 | 2021-12-31 | 2022-12-31 | 2023-12-31 | 2024-12-31 | |
|---|---|---|---|---|---|---|
| Cash and Equivalents | $4.2M | $112.3M | $65.5M | $43M | $33.8M | |
| Short Term Investments | -- | -- | $17.4M | $24.7M | $35.7M | |
| Accounts Receivable, Net | $2.4M | $1.4M | $7.2M | $16.1M | $10.2M | |
| Inventory | -- | -- | -- | -- | $2M | |
| Prepaid Expenses | $1.3M | $930K | $577K | $1.2M | $1M | |
| Other Current Assets | $203K | $252K | $1.1M | $652K | $3M | |
| Total Current Assets | $8.4M | $115.1M | $92.8M | $86.9M | $86M | |
| Property Plant And Equipment | $2.4M | $2M | $1.8M | $1.5M | $1M | |
| Long-Term Investments | -- | $15.4M | $20M | -- | $6M | |
| Goodwill | -- | -- | -- | $4.7M | $4.7M | |
| Other Intangibles | -- | -- | -- | $69.2M | $69M | |
| Other Long-Term Assets | $438K | $438K | $724K | $9.9M | $11.4M | |
| Total Assets | $11.2M | $132.9M | $115.3M | $172.3M | $178.1M | |
| Accounts Payable | $1.2M | $516K | $3.6M | $14M | $13.1M | |
| Accrued Expenses | $5.5M | $2.5M | $2.6M | $14.4M | $12.4M | |
| Current Portion Of Long-Term Debt | $390K | -- | -- | $37.7M | -- | |
| Current Portion Of Capital Lease Obligations | $499K | $371K | $480K | $543K | $420K | |
| Other Current Liabilities | -- | $821K | $5.4M | $7.1M | $8.2M | |
| Total Current Liabilities | $7.5M | $4.2M | $12M | $73.7M | $34.1M | |
| Long-Term Debt | $68M | -- | $12.8M | $5.1M | $59.5M | |
| Capital Leases | -- | -- | -- | -- | -- | |
| Total Liabilities | $77.6M | $5.8M | $40.2M | $110.5M | $138.5M | |
| Common Stock | -- | $4K | $3K | $4K | $5K | |
| Other Common Equity Adj | -- | -- | $113K | -$43K | $631K | |
| Common Equity | -$66.4M | $127.1M | $75.1M | $61.9M | $39.7M | |
| Total Preferred Equity | -- | -- | -- | -- | -- | |
| Minority Interest, Total | -- | -- | -- | -- | -- | |
| Total Equity | -$66.4M | $127.1M | $75.1M | $61.9M | $39.7M | |
| Total Liabilities and Equity | $11.2M | $132.9M | $115.3M | $172.3M | $178.1M | |
| Cash and Short Terms | $4.2M | $112.3M | $82.8M | $67.7M | $69.5M | |
| Total Debt | $68.4M | -- | $12.8M | $42.8M | $59.5M | |
| Period Ending | 2021-03-31 | 2022-03-31 | 2023-03-31 | 2024-03-31 | 2025-03-31 | |
|---|---|---|---|---|---|---|
| Cash and Equivalents | $75.9M | $100.2M | $40.2M | $42.8M | $37.3M | |
| Short Term Investments | -- | $1.3M | $55.1M | $9.9M | $25.3M | |
| Accounts Receivable, Net | $11.3M | $3.3M | $7.8M | $8.3M | $6.9M | |
| Inventory | -- | -- | -- | -- | $2.6M | |
| Prepaid Expenses | -- | -- | -- | -- | -- | |
| Other Current Assets | $395K | $880K | $1.2M | $1.9M | $3.8M | |
| Total Current Assets | $87.7M | $105.8M | $104.3M | $62.9M | $81.6M | |
| Property Plant And Equipment | $2.3M | $1.9M | $1.6M | $1.8M | $2.1M | |
| Long-Term Investments | -- | $17.6M | -- | -- | $6.1M | |
| Goodwill | -- | -- | -- | $4.7M | $4.7M | |
| Other Intangibles | -- | -- | -- | $67.7M | $67.4M | |
| Other Long-Term Assets | $437K | $437K | $673K | $14.2M | $10.9M | |
| Total Assets | $90.4M | $125.7M | $106.6M | $151.3M | $172.7M | |
| Accounts Payable | -- | -- | -- | -- | -- | |
| Accrued Expenses | -- | -- | -- | -- | -- | |
| Current Portion Of Long-Term Debt | $683K | -- | -- | -- | -- | |
| Current Portion Of Capital Lease Obligations | $455K | $363K | $470K | $583K | $589K | |
| Other Current Liabilities | $245K | -- | $5M | $6.5M | $8.6M | |
| Total Current Liabilities | $4.2M | $2.9M | $15.6M | $29.9M | $27M | |
| Long-Term Debt | $98K | -- | $12.9M | $43M | $60.1M | |
| Capital Leases | -- | -- | -- | -- | -- | |
| Total Liabilities | $6.2M | $4.2M | $35.2M | $102.5M | $131.7M | |
| Common Stock | $3K | $3K | $3K | $4K | $5K | |
| Other Common Equity Adj | -- | -- | -$63K | $141K | -$82K | |
| Common Equity | -- | -- | -- | -- | -- | |
| Total Preferred Equity | -- | -- | -- | -- | -- | |
| Minority Interest, Total | -- | -- | -- | -- | -- | |
| Total Equity | $84.3M | $121.5M | $71.4M | $48.8M | $41M | |
| Total Liabilities and Equity | $90.4M | $125.7M | $106.6M | $151.3M | $172.7M | |
| Cash and Short Terms | $75.9M | $101.6M | $95.3M | $52.7M | $62.6M | |
| Total Debt | $781K | -- | $12.9M | $43M | $60.1M | |
| Period Ending | 2020-12-31 | 2021-12-31 | 2022-12-31 | 2023-12-31 | 2024-12-31 | |
|---|---|---|---|---|---|---|
| Net Income to Stockholders | -$12.8M | -$8.6M | -$26.8M | -$46M | -$105.5M | |
| Depreciation & Amoritzation | $273K | $257K | $944K | $1M | $6.4M | |
| Stock-Based Compensation | $2.5M | $2.4M | $4.3M | $6M | $14.9M | |
| Change in Accounts Receivable | -$714K | $1.1M | -$6.8M | -$9.1M | $6.9M | |
| Change in Inventories | -- | -- | $147K | $206K | -$8.9M | |
| Cash From Operations | -$1.9M | $10.4M | -$18.7M | -$33.5M | -$69.7M | |
| Capital Expenditures | $33K | $102K | $93K | $296K | -- | |
| Cash Acquisitions | -- | -- | -$14.1M | -$30.4M | -- | |
| Cash From Investing | -$33K | -$15.5M | -$36.7M | -$17.4M | -$22.2M | |
| Dividends Paid (Ex Special Dividend) | -- | -- | -- | -- | -- | |
| Special Dividend Paid | ||||||
| Long-Term Debt Issued | $3.1M | -- | $12.8M | $42.4M | $59M | |
| Long-Term Debt Repaid | -$227K | -$38.1M | -$16K | -$17.5M | -$42.7M | |
| Repurchase of Common Stock | -- | -$2.8M | -$4.7M | -$3.4M | -- | |
| Other Financing Activities | -$118K | $73.9M | -$33K | $692K | -$1.4M | |
| Cash From Financing | $2.7M | $113.1M | $8.4M | $28.5M | $82.1M | |
| Beginning Cash (CF) | $3.6M | $4.3M | $112.3M | $65.5M | $43M | |
| Foreign Exchange Rate Adjustment | -- | -- | -- | -- | -- | |
| Additions / Reductions | $767K | $108M | -$47.1M | -$22.5M | -$9.7M | |
| Ending Cash (CF) | $4.3M | $112.3M | $65.5M | $43M | $33.8M | |
| Levered Free Cash Flow | -$2M | $10.3M | -$18.8M | -$33.8M | -$69.7M | |
| Period Ending | 2021-03-31 | 2022-03-31 | 2023-03-31 | 2024-03-31 | 2025-03-31 | |
|---|---|---|---|---|---|---|
| Net Income to Stockholders | -$10.3M | -$1.9M | -$13.2M | -$16.6M | -$3.1M | |
| Depreciation & Amoritzation | $64K | $65K | $79K | $1.6M | $1.6M | |
| Stock-Based Compensation | $675K | $918K | $945K | $2.1M | $3.1M | |
| Change in Accounts Receivable | -$8.7M | -$1.8M | $477K | $9.1M | -$2.1M | |
| Change in Inventories | -- | -- | $51K | -$2.6M | -$205K | |
| Cash From Operations | -$2.6M | -$3.6M | -$4M | -$16.2M | -$8.2M | |
| Capital Expenditures | -- | $16K | $29K | -- | $99K | |
| Cash Acquisitions | -- | -- | -- | -- | -- | |
| Cash From Investing | -- | -$3.8M | -$17.6M | $14.8M | $10.5M | |
| Dividends Paid (Ex Special Dividend) | -- | -- | -- | -- | -- | |
| Special Dividend Paid | -- | -- | -- | -- | -- | |
| Long-Term Debt Issued | -- | -- | $12.9M | -- | -- | |
| Long-Term Debt Repaid | -$38M | -$10K | -$12.8M | -- | -- | |
| Repurchase of Common Stock | -- | -$4.7M | -$3.4M | -- | -- | |
| Other Financing Activities | $37.4M | -- | -$415K | -- | -$372K | |
| Cash From Financing | $74.3M | -$4.7M | -$3.8M | $1.2M | $1.6M | |
| Beginning Cash (CF) | $4.3M | $112.3M | $65.5M | $43M | $33.8M | |
| Foreign Exchange Rate Adjustment | -- | -- | $65K | -$45K | -$372K | |
| Additions / Reductions | $71.7M | -$12.1M | -$25.4M | -$155K | $3.9M | |
| Ending Cash (CF) | $76M | $100.2M | $40.2M | $42.8M | $37.3M | |
| Levered Free Cash Flow | -$2.6M | -$3.6M | -$4.1M | -$16.2M | -$8.3M | |
| Period Ending | 2021-03-31 | 2022-03-31 | 2023-03-31 | 2024-03-31 | 2025-03-31 | |
|---|---|---|---|---|---|---|
| Net Income to Stockholders | -$17.3M | -$123K | -$38.1M | -$49.5M | -$92M | |
| Depreciation & Amoritzation | $265K | $258K | $958K | $2.5M | $6.5M | |
| Stock-Based Compensation | $2.1M | $2.7M | $4.3M | $7.1M | $15.9M | |
| Change in Accounts Receivable | -$9M | $8M | -$4.5M | -$483K | -$4.3M | |
| Change in Inventories | -- | -- | $198K | -$2.4M | -$6.5M | |
| Cash From Operations | -$2.5M | $9.5M | -$19.2M | -$45.7M | -$61.7M | |
| Capital Expenditures | $22K | $118K | $106K | $267K | $99K | |
| Cash Acquisitions | -- | -- | -$14.1M | -- | -- | |
| Cash From Investing | -$22K | -$19.4M | -$50.4M | $15M | -$26.4M | |
| Dividends Paid (Ex Special Dividend) | -- | -- | -- | -- | -- | |
| Special Dividend Paid | ||||||
| Long-Term Debt Issued | -- | -- | $25.7M | $29.5M | -- | |
| Long-Term Debt Repaid | -$38.2M | -$122K | -$12.8M | -$4.7M | -- | |
| Repurchase of Common Stock | -- | -$7.5M | -$3.4M | -- | -- | |
| Other Financing Activities | $37.3M | -- | -$448K | -- | -$1.8M | |
| Cash From Financing | $76M | $34.1M | $9.3M | $33.4M | $82.5M | |
| Beginning Cash (CF) | -- | -- | -- | -- | -- | |
| Foreign Exchange Rate Adjustment | -- | -- | -- | -- | -- | |
| Additions / Reductions | $73.5M | $24.2M | -$60.3M | $2.7M | -$5.6M | |
| Ending Cash (CF) | -- | -- | -- | -- | -- | |
| Levered Free Cash Flow | -$2.5M | $9.4M | -$19.3M | -$45.9M | -$61.8M | |
| Period Ending | 2021-03-31 | 2022-03-31 | 2023-03-31 | 2024-03-31 | 2025-03-31 | |
|---|---|---|---|---|---|---|
| Net Income to Stockholders | -$10.3M | -$1.9M | -$13.2M | -$16.6M | -$3.1M | |
| Depreciation & Amoritzation | $64K | $65K | $79K | $1.6M | $1.6M | |
| Stock-Based Compensation | $675K | $918K | $945K | $2.1M | $3.1M | |
| Change in Accounts Receivable | -$8.7M | -$1.8M | $477K | $9.1M | -$2.1M | |
| Change in Inventories | -- | -- | $51K | -$2.6M | -$205K | |
| Cash From Operations | -$2.6M | -$3.6M | -$4M | -$16.2M | -$8.2M | |
| Capital Expenditures | -- | $16K | $29K | -- | $99K | |
| Cash Acquisitions | -- | -- | -- | -- | -- | |
| Cash From Investing | -- | -$3.8M | -$17.6M | $14.8M | $10.5M | |
| Dividends Paid (Ex Special Dividend) | -- | -- | -- | -- | -- | |
| Special Dividend Paid | -- | -- | -- | -- | -- | |
| Long-Term Debt Issued | -- | -- | $12.9M | -- | -- | |
| Long-Term Debt Repaid | -$38M | -$10K | -$12.8M | -- | -- | |
| Repurchase of Common Stock | -- | -$4.7M | -$3.4M | -- | -- | |
| Other Financing Activities | $37.4M | -- | -$415K | -- | -$372K | |
| Cash From Financing | $74.3M | -$4.7M | -$3.8M | $1.2M | $1.6M | |
| Beginning Cash (CF) | $4.3M | $112.3M | $65.5M | $43M | $33.8M | |
| Foreign Exchange Rate Adjustment | -- | -- | $65K | -$45K | -$372K | |
| Additions / Reductions | $71.7M | -$12.1M | -$25.4M | -$155K | $3.9M | |
| Ending Cash (CF) | $76M | $100.2M | $40.2M | $42.8M | $37.3M | |
| Levered Free Cash Flow | -$2.6M | -$3.6M | -$4.1M | -$16.2M | -$8.3M | |
Get ZVRA Stock Alert
Signup to receive the latest stock alerts
Financial Ratios
ZVRA
Sector
P/E ratio
--
23.88x
PEG ratio
-0.14x
0.00x
P/B ratio
16.42x
1.80x
Price / LTM sales
14.97x
1.65x
Growth Metrics
ZVRA
Sector
Revenue growth
495.65%
4.06%
Earnings growth
--
7.46%
Revenue (5-year growth)
12.96%
8.01%
Earnings forecast
$1.61
-$0.20
Profitability
ZVRA
Sector
Profitability FY 2024
$16.2M
$47.5M
Return on invested capital
-89.91%
-16.26%
Return on assets
-54.88%
-13.27%
Return on equity
-198.46%
-18.61%
Earnings Date
Last Earnings Date
May
13
Next Earnings Date
Aug
13
Estimated Next Earnings Date
Aug
12
Balance Sheet
ZVRA
Sector
Total cash
$62.6M
$35.5M
Short term investments
$35.7M
$29.7M
Total assets
$178.1M
$106.9M
Long term debt
$60.1M
$7.1M
SEE THE 1% OF STOCKS YOU NEED TO OWN FOR MASSIVE RETURNS
GET BETTER TRADE IDEAS
Popular
Will FCX Benefit From Tariffs?
Freeport-McMoRan (NYSE:FCX) is among the world’s largest producers of copper…
Can Levi Stock Double?
Levi Strauss (NYSE:LEVI) is among the oldest clothing brands in…
Stock Ideas
Buy
70
Is NVDA Stock a Buy?
Market Cap: $4.2T
P/E Ratio: 58x
Buy
62
Is MSFT Stock a Buy?
Market Cap: $3.8T
P/E Ratio: 43x
Sell
40
Is AAPL Stock a Buy?
Market Cap: $3.1T
P/E Ratio: 35x
Alerts
Buy
82
SBET alert for Jul 17
SharpLink Gaming [SBET] is down 2.6% over the past day.
Buy
89
EXOD alert for Jul 18
Exodus Movement [EXOD] is down 4.14% over the past day.
Buy
60
U alert for Jul 17
Unity Software [U] is up 7.51% over the past day.
THE #1 STOCK ANALYSIS TOOL
TO MAKE SMARTER BUY AND SELL DECISIONS
Show me the best stock
